Some mammalian cells are able to divide via both the classic contractile ring-dependent method (cytokinesis A) and a contractile ring-independent, adhesion-dependent method (cytokinesis B). Cytokinesis A is triggered by RhoA, which, in HeLa cells, is activated by the guanine nucleotide-exchange factor Ect2 localized at the central spindle and These results suggest that equatorial Ect2 locally suppresses lamellipodia formation via RhoA activation, which indirectly contributes to restricting lamellipodia formation to polar regions during cytokinesis B.
Introduction
The final step in the process of cell division is cytokinesis, during which the cellular contents are divided and the two daughter cells are formed. Formation of the furrow that ultimately leads to separation of the two daughter cells is mediated in large part by RhoA (Kishi et al., 1993; Mabuchi et al., 1993; Jantsch-Plunger et al., 2000) , one of the Rho-type small GTPases which also include Rac1 and Cdc42; these mediators regulate actin dynamics during a variety of cellular events (reviewed by Etienne-Manneville and Hall, 2002) . In the classic "purse string" model of cytokinesis, actomyosin-dependent contraction of the contractile ring drives cleavage of the equatorial region (reviewed by Glotzer, 2005) . RhoA-dependent stimulation of actin polymerization through regulation of formins is crucial to formation of the contractile ring (Sagot et al., 2002; Kovar et al., 2003) , while phosphorylation of myosin light chain by Rho-associated kinase (ROCK) leads to myosin activation and contraction of the ring (Amano et al., 1996; Kimura et al., 1996; Piekny and Mains, 2002; Matsumura, 2005) .
Rho GTPases are activated by guanine nucleotide exchange factors (GEFs).
Among the numerous GEFs that have been identified, Ect2 (Epithelial cell transforming protein 2) has been shown to play a key role in cytokinesis. Ect2 was originally identified as a transforming protein in an expression-cloning assay (Miki et al., 1993) .
Its role in cytokinesis was first identified in studies of Drosophila melanogaster. The
Drosophila and Caenorhabditis elegans orthologues of Ect2, Pebble and LET-21, respectively, have both been shown to be required for contractile ring formation and cytokinesis (Prokopenko et al., 1999; Morita et al., 2005) . Although Ect2 appears to act as a GEF with all three Rho-type small GTPases in vitro, recent studies suggest that RhoA is the primary downstream target of Ect2 in vivo (Kimura et al., 2000; Yuce et al., 2005; Kamijo et al., 2006; Nishimura and Yonemura, 2006; Birkenfeld et al., 2007) .
Interestingly, under appropriate conditions in some cell types, cytokinesis proceeds fairly normally without contractile ring activity. For example, when adhering to a substrate, myosin II-null cells of the cellular slime mold Dictyostelium discoideum are able to divide by making use of traction forces, which move the daughter cells away from one another (Neujahr et al., 1997; Zang et al., 1997; Nagasaki et al., 2002) . This process was named "attachment-assisted mitotic cleavage" (Neujahr et al., 1997) or "cytokinesis B" to distinguish it from "cytokinesis A," which refers to the adhesion-independent, contractile ring-dependent "classic" cytokinesis (Zang et al., 1997; Nagasaki et al., 2002) . On highly adherent substrates, certain types of mammalian cells are also able to divide in an adhesion-dependent, contractile ring-independent manner when the activity of the contractile ring is blocked by the myosin II-specific inhibitor blebbistatin (Kanada et al., 2005) . In addition, Burton and Taylor (1997) reported a case of successful division of a fibroblast that was driven by traction forces after regression of the initial equatorial furrow under physiological culture conditions. This observation can be interpreted to mean that cytokinesis B is activated when cells fail to properly complete cytokinesis A, and that mammalian cytokinesis B serves as a backup mechanism. In that case, adherent mammalian cells capable of cytokinesis B must have a mechanism that enables them to make use of cytokinesis A or B to ensure successful cell division.
In the present study, we explored the functions of Ect2 in mammalian cytokinesis A and B using HeLa cells, which rely on cytokinesis A for division, and HT1080 human fibrosarcoma cells, which are able to divide using cytokinesis B when cytokinesis A is inhibited (Kanada et al., 2005) . Our findings provide the first direct evidence that Ect2 is dispensable for cytokinesis in certain types of mammalian cells, and that RhoA localized at the equatorial cortex is indirectly required for the maintenance of appropriate polar lamellipodia formation in mitotic cells undergoing cytokinesis B.
Materials and Methods

Plasmid construction and RNA interference
The construct for the dominant active form of human Ect2 (Ect2-DA, amino acids 415-884) was created by PCR from a HT1080 cDNA library using specific oligonucleotides and iProof High-Fidelity DNA polymerase (Bio-Rad, Tokyo, Japan), and was cloned into pEGFP-C3 (Clontech, Tokyo, Japan) in which the EGFP cDNA was replaced with mCherry cDNA. The mCherry expression plasmid (Shaner et al., 2004) was kindly provided by Dr. R. Y. Tsien. All DNA constructs were confirmed by sequencing.
Depletion of Ect2 was achieved using the shRNA expression vector piMARK (Nagasaki et al., 2007) , which mediates expression of both shRNA and the blasticidin resistance (Bsr) protein fused with enhanced green fluorescent protein (EGFP), enabling both rapid elimination of untransfected cells and visual identification of knockdown cells. The targeting sequence, GCAGTTGATGACTTTAGAA, was designed using Dharmacon's design algorithm (http://www.dharmacon.com/sidesign/default.aspx), which was followed by the loop sequence 5'-ACGTGTGCTGCTGTCCGT-3' and the sequence complementary to the target sequence. To confirm the depletion of Ect2, cell lysate was analyzed by Western blotting with anti-Ect2 (sc-1005, Santa Cruz Biotechnology, Santa Cruz, CA; 1: 200 dilution) and anti-β-actin (Clone AC-74, Sigma, Tokyo, Japan; 1:2,000 dilution) antibodies. The secondary antibody was horseradish peroxidase-conjugated anti-mouse antibody (474-1806, KPL, Gaithersburg, MD; 1:3,000 dilution). Chemiluminescence (Super Signal West Dura Extended Duration Substrate, Pierce, Rockford, IL) was detected using an Las-3000 imager (Fujifilm, Tokyo, Japan).
Cell Culture and Transfection
HT1080 cells (Rasheed et al., 1974) were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic-antimycotic (Invitrogen, Tokyo, Japan). HeLa S3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS and 1% antibiotic-antimycotic.
Cells were transfected with plasmids using Lipofectamine 2000 (Invitrogen).
Cells transfected with piMARK were maintained in the presence of blasticidin S at a concentration of 10 μg/ml for HeLa cells and 20 μg/ml for HT1080 cells.
Observation of Live Cells
To assess cytokinesis B in HT1080 cells, untreated polystyrene dishes (Asahi Techno Glass, Tokyo, Japan) were coated with 0.01% collagen type Ι solution (IFP 9660, Research Institute for the Functional Peptides, Yamagata, Japan) overnight (Kanada et al., 2005) . The S-(-)-enantiomer of blebbistatin (Toronto Research Chemicals, Toronto, Ontario, Canada) used to inhibit myosin II, and thus cytokinesis A, was dissolved at 10 mM in DMSO. CT04 (Cytoskeleton Inc., Denver, CO), the cell permeable derivative of C3 exoenzyme, was dissolved at 200 μg/ml in 50 % glycerol. HT1080 cells were incubated in the presence of 5 μg/ml CT04 for 2 hours under the growth condition before observation.
Cells were maintained at a constant temperature in stage incubators (Onpu-4; Taiei Denki, Kasama, Japan; or MI-IBC, Olympus, Tokyo, Japan) attached to inverted microscopes (IX50 or IX71; Olympus) and observed using a 20X objective with or without phase-contrast optics for differential interference contrast. Images were captured using a CCD camera (ORCA-AG or ORCA-ER; Hamamatsu Photonics, Hamamatsu, Japan) controlled with the IPLab software (Solution Systems, Funabashi, Japan).
Immunofluorescence
Cells were fixed in either 10% trichloroacetic acid (TCA) for 15 min (for RhoA staining) (Yonemura et al., 2004) or 3% formaldehyde, 2% sucrose in 6 phosphate-buffered saline (PBS) for 30 min (for Ect2 staining), washed twice with PBS, and treated with 0.1% Triton X-100 in PBS for 5 min.
To assess cytokinesis B, the hydrophilic surfaces of glass-bottomed dishes (Asahi Techno Glass) were treated with hexamethyldisilazane (Shin-Etsu Chemical, Tokyo, Japan) to increase its hydrophobicity before coating it with collagen as described above.
Forty-five min after addition of blebbistatin (30 μM), cells on collagen-coated glass-bottomed dishes were fixed with appropriate reagents.
Cells were stained with either anti-RhoA (sc-418, Santa Cruz Biotechnology; 1:200 dilution) or anti-Ect2 (sc-1005, Santa Cruz Biotechnology; 1:100 dilution)
antibody, followed by a mixture of Alexa 546-or 488-conjugated anti-mouse-IgG or anti-rabbit-IgG (Invitrogen) and 1 μg/ml Hoechst 33258 (Wako Pure Chemical, Osaka, Japan).
Immunostained cells were observed using an inverted microscope (IX-70, Olympus) equipped with a confocal laser scanning unit (CSU 10, Yokogawa, Tokyo, Japan) or epifluorescence optics.
Activation Assay for Rho GTPases
Relative levels of active RhoA and Rac1 were estimated using the method described by Ren and Schwartz (2000) and Benard and Bokoch (2002) , respectively, with slight modifications. Recombinant GST-RBD and GST-PBD were prepared and conjugated with glutathione-Sepharose 4B (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). HT1080 cells on collagen-coated culture dishes were transfected with mCherry or mCherry-Ect2-DA expression vectors. To assay RhoA activity, cells were lysed 24 h after transfection in RIPA buffer containing 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate and 10% glycerol supplemented with 1 mM dithiothreitol, 50 mM NaF, 1 mM NaVO 4 , 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.5 μg/ml leupeptin, 0.7 μg/ml pepstatin, 70 μg/ml tosyl phenylalanylchloromethyl ketone, 75 μg/ml p-toluenesulfonyl-L-arginine methyl ester, 2 μg/ml aprotinin and 160 μg/ml benzamidine. To assay Rac1 activity, cells on collagen-coated dished were lysed 24 h after transfection in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100 and 10% glycerol supplemented with 1 mM dithiothreitol, 50 mM NaF, 1 mM NaVO 4 and the protease inhibitors. Lysates were clarified by centrifugation and then incubated with GST-RBD or GST-PBD beads for 45 min at 4°C with gentle agitation. The beads were then spun down and washed 5 times with lysis buffer. Total lysate and pull-downs were analyzed by Western blotting using 
Results
Ect2 is not essential for HT1080 cell growth
We initially used immunofluorescence microscopy to examine the spatial relationship between RhoA and Ect2 during cytokinesis in HeLa and HT1080 cells.
RhoA was immunostained in cells fixed with TCA, which has been known to preserve active RhoA (Yonemura et al., 2004; Yuce et al., 2005) , while Ect2 was immunostained in cells fixed with formaldehyde. We confirmed the findings of an earlier study (Chalamalasetty et al., 2006) showing that RhoA accumulated at the equatorial cortex during anaphase in both HeLa and HT1080 cells ( Figure 1A , left panels). Ect2 To study the function of Ect2 during cytokinesis in the two cell lines, we next 8 depleted Ect2 using a novel shRNA vector, piMARK (Nagasaki et al., 2007) . Cells harboring piMARK and expressing shRNA were selected by culture in the presence of blasticidin S, and efficient depletion of Ect2 was confirmed by Western blot analysis carried out 48 h and 72 h after transfection ( Figure 1B ). Inhibition of cytokinesis in Ect2-depleted cells was then evaluated morphologically. When assessed 72 h after transfection, Ect2 depletion resulted in 59% of HeLa cells being multinucleate ( Figure   1C ), which was consistent with earlier studies (Tatsumoto et al., 1999; Kimura et al., 2000; Kim et al., 2005) . By contrast, only 18% of HT1080 cells were multinucleate.
During extended culture, all of the Ect2-depleted HeLa cells became severely multinucleated and eventually died. On the other hand, with selection in the presence of blasticidin S, a large number of HT1080 cell colonies emerged in which expression of Ect2 was stably suppressed. This enabled us to establish nine cell lines in which the majority of cells were mononucleate, though expression of Ect2 was strongly suppressed. In the cell line chosen for further characterization, the expression of Ect2 was suppressed by greater than 90%, as determined by densitometric analysis of Western blots. Immunofluorescence staining of these cells revealed that the amount of Ect2 at the spindle structures was reduced to an undetectable level ( Figure 1D ). These unexpected results indicate that whereas Ect2 is essential in HeLa cells, it is dispensable for cytokinesis and growth in HT1080 cells.
Effects of Ect2 depletion on the progression of cytokinesis A
We used time-lapse video microscopy to analyze the effects of Ect2 depletion on the progression of cytokinesis A in mitotic HT1080 cells. In control cells, smoothly curved, U-shaped furrows began to form in the lateral equatorial region 2.7 ± 0.5 min (average ± SD; N = 6) after the onset of anaphase (3 and 4 min after anaphase onset, Figure 2A ). The furrows became V-shaped as the ingression grew deeper, and the ingression was complete in about 6.3 ± 1.9 min. By contrast, Ect2-depleted cells formed lateral cleavage furrows that were V-shaped from the beginning (6 min after anaphase onset, Figure 2A ). These cells took a longer time to form cleavage furrows (4.7 ± 0.5 min; N = 6, after anaphase onset), but showed rapid ingression that was completed in 2.8 ± 0.8 min once the furrow was formed (Figure 2A , B and Supplemental Movie 1, 2 at http://staff.aist.go.jp/m-kanada/ect2mov.html). The accelerated ingression in Ect2-depleted cells suggests that one of the functions of Ect2 present at the central spindle is temporal regulation of the ingression process through regulation of the behavior of the equatorial cortex via RhoA or some other factor(s).
O 'Connell et al. (1999) reported that Botulinum C3 exoenzyme (C3) did not prevent furrow ingression in normal rat kidney (NRK) cells or 3T3 fibroblasts. In addition, a recent fluorescence resonance energy transfer analysis showed that entire process of cytokinesis in Rat1 cells does not involve RhoA activation (Yoshizaki et al., 2004) . These earlier studies suggest the possibility that HT1080 cells also divide in a manner independent of RhoA activation at the equatorial cortex. To examine this possibility, the cell permeable derivative of C3 was loaded into HT1080 cells. The C3-loaded cells failed to accumulate RhoA at the equatorial cortex (Supplemental Figure 1A ), and were unable to form equatorial furrows (N = 6; Supplemental Figure 1B and Movie 7 at http://staff.aist.go.jp/m-kanada/ect2mov.html). Furthermore, immunofluorescence microscopy of Ect2-depleted HT1080 cells revealed that RhoA accumulated at the equatorial cortex, though the region in which it accumulated was narrower than in control cells ( Figure 2C ). We thus conclude that active RhoA, presumably at the equatorial cortex, is necessary for cytokinesis of HT1080 cells, but that Ect2 is not the primary GEF mediating activation of RhoA at the equatorial cortex of HT1080 cells.
Effects of Ect2 depletion on the progression of cytokinesis B
We then used time-lapse video microscopy to examine the effects of Ect2 depletion on blebbistatin-induced cytokinesis B in HT1080 cells. In the presence of 30 μM blebbistatin, 15/15 control mitotic cells on collagen-coated substrates rounded up slightly and then respread extending polar lamellipodia immediately following the onset of anaphase. Thereafter, the lamellipodia grew and became large and fan-shaped around the two poles accompanied by formation of tight equatorial furrows ( Figure 3A and Supplemental Movie 3 at http://staff.aist.go.jp/m-kanada/ect2mov.html). Only two of the 15 cells that formed tight furrows in the presence of 30 μM blebbistatin completed the division to yield separate daughter cells within 2-h; in the remaining 13 pairs, thin cytoplasmic bridges connecting the well-separated daughter cells persisted. Six of those 13 pairs were observed for another 6-h, and four pairs completed the scission while the remaining two pairs eventually fused back to form binucleate cells. Thus, the overall success rate of cytokinesis B of HT1080 cells on collagen coated surfaces in the presence of 30 µM blebbistatin was estimated to be 71%, although all of them temporalily formed tight equatorial furrows.
In contrast to this, the 13 Ect2-depleted cells observed in detail exhibited three distinct types of morphological abnormalities during cytokinesis B induced by blebbistatin. Five cells were classified as "delayed" ( Figure 3B and Supplemental Movie 4 at http://staff.aist.go.jp/m-kanada/ect2mov.html). This group showed a delay in respreading following the onset of anaphase; all other processes during cytokinesis B appeared normal. Six cells were classified as "delayed and uncoordinated" ( Figure 3C and Supplemental Movie 5 at http://staff.aist.go.jp/m-kanada/ect2mov.html). This group was characterized by compromised pole-to-equator polarity in the presumptive daughter cells during the respreading process. They formed uncoordinated lamellipodia around the poles and ectopic lamellipodia near the equatorial region, as well as delay in respreading. Nevertheless, all of these cells eventually formed tight furrows in their equatorial regions ( Figure 3C at 50 min). The remaining two cells were classified as "delayed and one-sided" ( Figure 3D and Supplemental Movie 6 at http://staff.aist.go.jp/m-kanada/ect2mov.html). This group also showed a delay before respreading, after which one side of the cells began respreading before the other side started. Although one of these two cells did form a furrow briefly, it immediately regressed, leaving a binucleate cell. The other cell did not even form a slight furrow, again resulting in formation of a binucleate cell. Two of the 11 Ect2-depleted cells that formed tight furrows in the presence of 30 μM blebbistatin completed the division; thin cytoplasmic bridges connecting the well-separated daughter cells in the remaining nine pairs persisted during the 2-h observation period. It thus appears that there is no significant difference in the success rate of cytokinesis B between control and Ect2-depleted cells.
To quantitate the efficiency of opposite migration polarity, we measured changes in distance from pole to pole during cytokinesis B in the control and Ect2-depleted cells ( Figure 3E ). The "one-sided" group was excluded from this analysis because expansion between the two poles was unobservable. We found that the rate in increase in the pole-to-pole distance in control cells was about twice that in Ect2-depleted cells. Taken together, the most striking differences between control and Ect2-depleted cells in the presence of blebbistatin are that, unlike conrol cells, Ect2-depleted cells fail to form polar lamellipodia immediately following the onset of anaphase, and to maintain appropriate lamellipodial activities throughout cytokinesis B.
Narrower accumulation of RhoA at the midzone cortex in Ect2-depleted cells undergoing cytokinesis B
Because Ect2 appeared necessary for the formation and maintenance of polar lamellipodia during cytokinesis B, we next used a combination of immunofluorescence and phase-contrast microscopy to study the relationship between the localization of RhoA and lamellipodia formation in the presence of blebbistatin ( Figure 4A ).
TCA-fixed control cells with two large fan-shaped polar lamellipodia showed broad accumulation of RhoA over a large area of the equatorial cortex. Within this region, lamellipodia formation was strongly inhibited. On the other hand, Ect2-depleted cells of the "delayed and uncoordinated" type showed narrower accumulation of RhoA at the equatorial cortex, in a region only above the central midzone. To compare the levels of RhoA present in the equatorial region in control and Ect2-depleted cells, we calculated the ratios of the total fluorescence in the equatorial region over that in the region where the lamellipodia formed. The amount of RhoA present in the equatorial region of fixed cells was reduced to 45% of control in Ect2-depleted cells ( Figure 4B ). The diminished RhoA levels were accompanied by weaker inhibition of lamellipodia formation, which was restricted to a narrower region than in control cells, so that ectopic lamellipodia formed in regions where they normally would be inhibited. This result suggests that RhoA present at the equatorial cortex suppresses formation of lamellipodia there during cytokinesis B and that Ect2 is involved in the broad cortical accumulation of RhoA over the midzone.
Rho activity is required for distinctive polarity formation during cytokinesis B in
HT1080 cells
C3 inhibited the formation of equatorial furrows in HT1080 cells on surfaces without collagen coating (Supplemental Figure 1B and Movie 7 at http://staff.aist.go.jp/m-kanada/ect2mov.html). Thus, in C3-loaded mitotic HT1080 cells, the RhoA activity was inhibited to the extent that the myosin II-dependent contractile activity of the cleavage furrow was almost completely abolished. This prompted us to ask whether these cells are able to carry out cytokinesis B in the absence of RhoA activity when placed on collagen-coated substrates, in a manner similar to blebbistatin-treated cells. The C3-loaded cells on collagen-coated substrates hardly formed polar lamellipodia after the onset of anaphase. At 27.8 ± 3.6 min (average ± SD; N = 13) after the onset of anaphase, these cells suddenly formed lamellipodia all along the cell periphery, resulting in formation of binucleate cells ( Figure 5B and Supplemental movie 8 at http://staff.aist.go.jp/m-kanada/ect2mov.html). It thus appears that the mechanism that regulates lamellipodia formation was dramatically switched from Rho-dependent to Rho-independent at around 28 min after the onset of anaphase of cytokinesis B. Furthermore, this result indicates that the Rho activity is required for 13 the formation of distinctive polarity during cytokinesis B in HT1080 cells.
A dominant active form of Ect2 suppresses formation of lamellipodia through enhancement of RhoA activity
Ect2 reportedly increases the rate of guanine nucleotide exchange by all three Rho-type small GTPases in vitro (Tatsumoto et al., 1999) . In addition, Westwick et al. (1998) suggested that an oncogenic form of mouse Ect2 induces both lamellipodia formation via Rac1 activation and stress fiber formation via RhoA activation in one type of endothelial cell. These two results suggest the possibility that Ect2 directly enhances Rac1 activity in the polar regions of HT1080 cells undergoing cytokinesis B. To determine whether Ect2 directly enhances Rac1 and/or RhoA activity in HT1080 cells, we examined the effects of a dominant active form of Ect2 (Ect2-DA) (Saito et al., 2004) . For this purpose, Ect2-DA was fused to a monomeric red fluorescent protein, mCherry, which has been proven less toxic than other red fluorescent proteins (Shaner et al., 2004) , and was overexpressed in interphase HT1080 cells.
We first used confocal microscopy to confirm that Ect2-DA localized at the cell cortex of interphase HT1080 cells ( Figure 6A ). The majority of cells expressing mCherry-Ect2-DA did not spread on the poorly adherent glass-bottomed dishes, even after 6 h of culture, whereas the control cells expressing mCherry spread completely within this period. We next used time-lapse video microscopy to observe lamellipodia formation by cells plated on highly adherent collagen-coated surfaces. Control cells showed distinct motility ( Figure 6B and Supplemental Movie 9 at http://staff.aist.go.jp/m-kanada/ect2mov.html) with lamellipodia at defined locations along the periphery. In cells expressing constitutively active mutant of Rac1 (V12-Rac1), a prominent lamellipodium was formed all along the periphery (Supplemental Figure 2C (1998), and focal adhesions over the whole basal cell membrane (Supplemental Figure   2A and 2B).
Cells expressing mCherry-Ect2-DA were able to grow at a reasonable rate in the presence of G418 for more than one month, and the above-mentioned phenotype was maintained during this period (Supplemental Movie 12 at http://staff.aist.go.jp/m-kanada/ect2mov.html). This rules out the possibility that mCherry-Ect2-DA exerts a general toxic effect to the cells and that this caused the severe inhibition of lamellipodial formation and cell migration.
Finally, to determine the effects of mCherry-Ect2-DA on the activities of small GTPases, we used pull down assays to assess the activities of RhoA and Rac1 in cells expressing mCherry alone or mCherry-Ect2-DA on collagen-coated surfaces. RhoA activity was enhanced by more than 2 fold in mCherry-Ect2-DA expressing cells. In contrast, the expression of mCherry-Ect2-DA had a weak inhibitory effect on Rac1 ( Figure 6C ). Apparently, Ect2 predominantly regulates the activity of RhoA in HT1080 cells.
Discussion
Different roles of Ect2 during different phases of cytokinesis A
We investigated the activities of the GEF Ect2 during cytokinesis in HeLa cells, which rely on cytokinesis A for division, and HT1080 cells, which are able to use both cytokinesis A and cytokinesis B. The results of immunofluorescence staining, as well as of Ect2 knockdown experiments, provided the first evidence strongly suggesting that Ect2 is dispensable and that a substitute GEF can mediate activation of RhoA to form a contractile ring in certain types of mammalian cells, including HT1080 cells. VAV3 (Fujikawa et al., 2002) , MyoGEF (Wu et al., 2006) and GEF-H1 (Birkenfeld et al., 2007) are other GEFs reportedly involved in activation of RhoA during cytokinesis.
Thus, one of these GEFs might play a major role to form a contractile ring in HT1080 cells.
Recently, Chalamalasetty et al. (2006) showed that in HeLa cells an N-terminal fragment of Ect2 (N-Ect2) that acts as a dominant negative form of Ect2 (Tatsumoto et al., 1999; Kimura et al., 2000; Yoshizaki et al., 2004) does not prevent furrow ingression, but does prevent abscission, while RNAi-dependent Ect2 depletion does prevent furrow formation. They concluded that a physiological level of Ect2 is not required at the central spindle for cytokinesis in HeLa cells, based on the observation that N-Ect2 displaced endogenous Ect2 incompletely from the central spindle. However, N-Ect2 lacks the membrane localization domain and is unlikely to displace endogenous Ect2 on the cortex. We thus propose another explanation: that in HeLa cells overexpressing N-Ect2, cortical Ect2 is sufficient to mediate formation of cleavage furrows. Depletion of the microtubule bundling protein PRC1 disrupts the central spindle, resulting in dispersal of the centralspindlin complex (Mollinari et al., 2005) , but RhoA accumulates at the equatorial cortex, where it induces contractile ring formation and contraction (Nishimura and Yonemura, 2006) . This result is consistent with the above view, if Ect2 was also localized in the equatorial cortex in the absence of central spindle.
Still, these PRC1-depleted cells fail to carry out abscission (Mollinari et al., 2005; Nishimura and Yonemura, 2006) , which is consistent with the observation made in HeLa cells that accumulation of Ect2 at the central spindle is necessary for abscission (Chalamalasetty et al., 2006) . Contrary to this model, the Ect2-depleted HT1080 cells efficiently completed division. Perhaps migration of the daughter cells in opposite directions is sufficient to sever the cytoplasmic bridge in a midbody-independent manner. Consistent with that idea, we observed that under physiological culture conditions the majority of Ect2-depleted cells retained long, thin cytoplasmic bridges connecting the daughter cells after they had respread, and that migration of the daughter cells away from one another eventually broke this cytoplasmic bridge to complete cytokinesis. By contrast, most control HT1080 cells successfully completed the division without the oppositely-oriented migration of the daughter cells (Kanada and Uyeda, unpublished observations).
Regulation of lamellipodia formation by Ect2 during cytokinesis B
We found that Ect2-depleted HT1080 cells are slower to start respreading after the onset of anaphase during blebbistatin-induced cytokinesis B. They also fail to maintain the characteristic fan-shaped polar lamellipodia, resulting in formation of uncoordinated lamellipodia around the poles and ectopic lamellipodia near the equatorial regions.
Specific Rho GTPases are believed to regulate specific subsets of the actin cytoskeleton during cell migration, such that Rac promotes membrane protrusion at the leading edge, while Rho regulates contractility at the tail (Burridge and Wennerberg, 2004; Raftopoulou and Hall, 2004) . That Ect2-depleted HT1080 cells show delayed lamellipodia formation during anaphase suggests that, unlike equatorial RhoA activation for contractile ring formation during cytokinesis A, RhoA activation for lamellipodia formation during cytokinesis B mainly relies on Ect2. Furthermore, Ect2 is required to maintain appropriate polarity after anaphase. We also found that Ect2-depleted cells show narrower accumulation of RhoA at the cortex encircling the midzone and that inhibition of lamellipodia formation was restricted to that location. On the other hand, control cells showed broader accumulation of RhoA over the entire equatorial cortex, and lamellipodia formation was strongly suppressed in this region. Furthermore, experiments using C3 demonstrated that Rho activity is essential for the formation of distinctive polarity during cytokinesis B in HT1080 cells. Given these findings, we propose the following model for RhoA-dependent lamellipodia formation around the poles of mitotic cells undergoing cytokinesis B (Figure 7) . Upon entry into anaphase, RhoA begins to accumulate at the equatorial cortex to form distinctive polarity, which is dependent on partially redundant functions of Ect2 and the unidentified GEF. This contributes to recruitment of the elements involved in lamellipodia formation to the poles, so that lamellipodia are formed around both poles. Thereafter, equatorial RhoA contributes to prevention of lamellipodia formation in that region, thereby maintaining the appropriate polarity. In this model, RhoA acts indirectly to promote polar lamellipodia formation during cytokinesis B. This view is, however, inconsistent with the fact that the global inhibition of RhoA by C3 prevented lamellipodia formation during the first half hour after the anaphase onset. Therefore, there seems to be an abrupt, qualitative change in dependence of lamellipodia formation on RhoA activities at about half hour after the onset of anaphase during cytokinesis B. During this first period of cytokinesis B, a smaller amount of RhoA may directly contribute to polar lamellipodia formation. This view is consistent with the report that RhoA directly regulates membrane protrusion at the cell periphery (Fukata et al., 1999; Palazzo et al., 2001; Pertz et al., 2006) . Finally, we reported that Ect2-DA severely inhibits normal lamellipodia formation and enhances RhoA activity. These findings indicate that Ect2 mainly regulates activation of RhoA in HT1080 cells, though it regulates all three Rho-type small GTPases in vitro. It has been reported that under certain circumstances reciprocal balance between Rho-type small GTPases determines cellular morphology and behavior (reviewed by Uyeda et al., 2004) . In our experiment, the activity of Rac1 was not dramatically suppressed by overexpression of Ect2-DA, though the activity of RhoA was strongly enhanced. We suggest that during cytokinesis active RhoA might regulate Rac1 effecter proteins such as p21-activated kinase (PAK) independently of Rac1 activity. Although there is currently no evidence directly pointing to such signaling pathways, there is some evidence that one member of the small GTPase family may regulate the effecter of another member. For example, down regulation of Rac1 induces phosphorylation of myosin light chain kinase, which in turn phosphorylates myosin II in the absence of RhoA activation (Mandato et al., 2000; Yoshizaki et al., 2004) . 
